Koppel Adam 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Oct 18, 2023
Insider Transaction Report
Form 4
Koppel Adam
Director10% Owner
Transactions
- Purchase
Common Stock
2023-10-16$22.81/sh+5,480,052$124,999,986→ 65,679,781 total(indirect: See footnotes)
Holdings
- 3,282
Common Stock
Footnotes (2)
- [F1]Represents shares of the Issuer's common stock held directly by BC Perception Holdings, LP ("BC Perception"). Adam Koppel is a Partner of Bain Capital Life Sciences Investors, LLC. As a result, Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC Perception. Dr. Koppel disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
- [F2]On October 16, 2023, BC Perception purchased 5,480,052 shares of the Issuer's common stock at a price of $22.81 per share in an underwritten public offering.